goldennet

IDT新知分享-Overcome challenges in cancer research with IDT’s xGen™ NGS solutions for MRD detection and methylation profiling

Next-generation sequencing (NGS) has revolutionized cancer research, enabling deeper insights into tumor biology, clonal evolution, and therapeutic resistance. However, the complexity of cancer samples—often degraded, limited in quantity, or highly heterogeneous—poses significant challenges to accurate genomic profiling. In this presentation, we showcase how xGen™ NGS solutions empower researchers to overcome these obstacles, delivering robust performance across a wide range of sample types and variant detection needs.
We highlight the integration of optimized library preparation chemistries and hybridization capture technologies workflows that enable sensitive and specific detection of low-frequency somatic variants, even in FFPE and liquid biopsy samples, which further accelerating biomarker discovery, early cancer detection and innovative MRD research.
By combining high-quality data output with streamlined workflows, xGen™ NGS solutions provide a powerful toolkit for cancer researchers seeking to push the boundaries of precision oncology.